Rebalix
iShares · sheet of 10 September 2026
iShares · sheet of 10 September 2026ETF sheet · official issuer and register data
iShares Global Real Estate Environmental Tilt UCITS ETF
GRET · IE000PL3UFC3 · USD · domicile Ireland
Real estate (REIT) · GlobalSFDR art. 8
Index tracked: : FTSE EPRA Nareit Developed Green Low Carbon Target Select UCITS Capped Net Tax Index
- TER
- 0.18%+ trans. 0.06%
- Fund size
- 13 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (optimised)
- Income
- Distributingsemi-annual
Launch 26 Jun 2024 · costs from the KID as of 2 Sept 2026 · 322 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund which aims to achieve a return on your investment, taking into account both capital and income returns, which reflects the return of the FTSE EPRA Nareit Developed Green Low Carbon Target Select UCITS Capped Index (Index). The Share Class, via the Fund, is passively managed and aims to invest so far as possible and practicable in the equity securities that make up the Index and comply with the Environmental, Social and Governance (“ESG”) requirements and other eligibility criteria of the Index. The Index aims to reflect the performance of a…
Performance since series start (in euro) — base 100
26 Jun 2024 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +10.4% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +17.6% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.12% | 11.12% | — |
| Max drawdown | −10.07% | −10.07% | — |
| Sharpe | 0.35 | 0.35 | — |
| Sortino | 0.50 | 0.50 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · GRET · IE000PL3UFC31
RebalixGRET · IE000PL3UFC3 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +9.93% | +9.60% | +0.33% |
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.18 USD (3.07% of NAV) · last ex-date 16 Jul 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.18 | — |
| 2025 | 2 | 0.18 | +3.45% |
| 2024 | 1 | 0.01 | — |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 322 securities · top-10 weight = 41.4%
| Top holdings | Weight |
|---|---|
| 9.0% | |
| 6.5% | |
| 5.9% | |
| 5.2% | |
| 3.0% | |
| 3.0% | |
| 2.7% | |
| 2.4% | |
| 2.0% | |
| 1.8% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000PL3UFC3
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000PL3UFC3
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · GRET · IE000PL3UFC32